Bernie Sanders urged Denmark to force its most valuable company, Novo Nordisk A/S, to lower its drug prices, in a letter submitted by the US senator to one of the Nordic country’s largest newspapers.
Sanders Urges Denmark to Pressure Novo Nordisk on Lowering Drug PricesWho’s Who in South Africa’s Tightest Post-Apartheid ElectionSocialist Election Win in Catalonia May Upend Spain’s GovernmentBiden’s China Tariffs Salvo to Range From Doubling to QuadrupleBOJ Shouldn’t Delay Normalization Over Risks, LDP Official SaysPhilippine Civilians Risk China Faceoff in Sail to Disputed SeaChina Exploring Disputed Shoal for Reclamation, Philippines SaysNetanyahu Trades Insults With Colombia President...
Bank Has AI In Its FX Intervention CornerMorgan Stanley to Add 100 Jobs in Paris Hub, Le Maire SaysThe U.S. Fed is failing in four ways: Mohamed A. El-ErianRemote Working Boom Is Huge for College Towns Like KnoxvilleDismal U.S.
Canada Latest News, Canada Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
Ozempic Subsidies Cut in Novo Nordisk’s Home Country of DenmarkSubsidies for Ozempic will be restricted in Novo Nordisk A/S’s home country of Denmark due to rising public spending on the blockbuster diabetes medicine, which is increasingly being used as a weight-loss treatment.
Read more »
Novo Nordisk drops 5% after rival Amgen teases weight-loss drug dataExplore stories from Atlantic Canada.
Read more »
Novo Nordisk slides while Moderna pops: Tale of two pharma stocksPharmaceutical stocks Novo Nordisk (NVO) and Moderna (MRNA) are trending in opposite directions following their earnings reports. Despite topping Wall...
Read more »
Novo Nordisk sales up 26% driven by GLP-1s, misses 11% on WegovyNovo Nordisk CEO Lars Jørgensen tells Yahoo Finance the company is confident about a robust GLP-1 sales year despite missing Wall Street estimates.
Read more »
Novo Nordisk CEO on weight-loss drugs' 'exciting growth story'Danish pharmaceutical company Novo Nordisk (NVO) topped first-quarter profit expectations, bringing in $9.5 billion in revenue over Wall Street estimates of ...
Read more »
Novo Nordisk raises 2024 outlook as company races to boost output of Wegovy weight-loss drugNovo Nordisk reported better-than-expected first-quarter profits on Thursday as it looks to fend off competition from rival Eli Lilly
Read more »